We have a dedicated Industry Manager who works with all our NHS organisations to ensure that they can meet the health research needs of industry. The industry manager offers a single point of contact for all services:
Dr Chris Smith
Tel: 0151 331 5124
Benefits of Working in Cheshire & Merseyside
Cheshire & Merseyside has a population of ~2.7million, served by 18 NHS Trusts and eight PCTs. We have many clinicians actively seeking to participate in industry sponsored research across a wide range of specialties including:
|Age and ageing ||Health services research ||Non-malignant haematology|
|Anaesthetics, peri-operative medicine and pain ||Hepatology ||Ophthalmology|
|Cardiovascular ||Immunology and inflammation ||Oral and dental|
|Critical care ||Infectious diseases and microbiology ||Paediatrics (non-medicines) Renal|
|Dermatology ||Injuries and emergencies ||Reproductive health and childbirth|
|Ear, nose and throat ||Metabolic and endocrine ||Respiratory|
|Gastrointestinal ||Musculoskeletal |
|Genetics ||Nervous systems disorders |
Network staff are in place to set-up and deliver studies – pharmacists, technicians, research nurses, studies officers, clinical trial administrators, research management & governance teams.
All of our NHS organisations work with the NIHR industry costing template and mCTA, reducing the period of negotiation during set-up.
How we help Investigators
Investigators taking part in industry sponsored studies can access the various supports provided by the CLRN, including:
- CLRN funded infrastructure
- Support of CLRN Industry Manager
- Streamlined rapid setup and RM&G
- CLRN Nursing support
- CLRN and NIHR Training courses
- Cross-Network working, advertising and signposting
There are two ways to engage with NIHR CRN Portfolio Industry studies through the CLRN:
1. Pre-Selected Sites
The sponsor has previously contacted investigators directly to take part in a study. The CLRN supports these sites and provides necessary resources required. These sites work as a CLRN supported site. The CLRN support satisfies one aspect of the Portfolio adoption process for each study.
2. Expression of Interest
The sponsor asks the NIHR CRN for help to identify potential investigators for their study. This is facilitated by the CLRNs, and through the various local Specialty Groups. A blinded summary of the study design, schedule, eligibility criteria etc is circulated to investigators for consideration. Invitations to register an Expression of interest are invited from investigators. Registering an Expression of Interest DOES NOT commit an investigator to take part in the study at this stage. Sufficient interest registered facilitates the NIHR CRN Portfolio adoption process. Again the CLRN supported site plays a role in the success of NIHR CRN Portfolio adoption.